Introduction The risk of infections associated with biological drugs (BD) and Janus kinase
inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth …

Obesity is a major public health concern associated with a higher risk of various
comorbidities. Some studies have explored the impact of obesity on cognitive function and …

Background Systemic Janus kinase inhibitors (JAKi) and dupilumab both have emerged as
promising therapeutics for atopic dermatitis (AD). Dupilumab has a favorable safety profile …

Background Clinicians and healthcare policymakers have been drenched with a deluge of
overlapping meta-analyses (MAs), and the necessity for comprehensive and clearly defined …

Introduction Up to 25% of children and 5.6% of adults in the USA have atopic dermatitis
(AD), with substantial impacts on quality of life. Effective control can be challenging despite …

Background The escalating utilization of assisted reproductive technology (ART) in
response to global infertility rates has spurred research into its complications. Short-term …

Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently
approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a …

Introduction Alopecia areata (AA) is an immune-mediated disease that causes non-scarring
hair loss. While acute, solitary patches often spontaneously remit, developing secondary …

Background: Given the widespread prevalence of breast cancer as a global malignancy,
there is a compelling need to delve into its risk determinants. Objective: This study aims to …

Psoriasis is an inflammatory skin disease with a chronic relapsing course and an often-
detrimental impact on patients' quality of life. Thanks to incredible advances in research over …